Analysis of CD26 mediated signal transduction mechanism.
Analysis of CD26 mediated signal transduction mechanism.
批准号:
09044266
负责人:
MORIMOTO Chikao
金额:
$2.56万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for international Scientific Research
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998
中文摘要
CD26是一种110 kDa的细胞表面糖蛋白,具有二肽基肽酶IV(DPPIV;EC3.4.14.5)活性,在T细胞共刺激中发挥重要作用。以β-趋化因子为趋化因子,检测CD26/二肽基肽酶IV在跨内皮细胞迁移中的作用。当可溶性重组CD26(sCD26/DPPIV^+)加入到经内皮细胞趋化系统中时,T细胞向RANTES的趋化迁移显著增强。在50 ng/mlRANTES中加入sCD26,与单独加入RANTES相比,迁移反应增强2倍,而缺乏DPPIV酶活性的突变型可溶性CD26对RANTES诱导的T细胞迁移没有增强作用。在分析sCD26促进T细胞迁移的机制的过程中,我们发现在生理条件下,RANTES被sCD26在其酶特异性的精确位置上切割。然而,合成的RANTES缺乏两个N-末端的氨基a-…更多的CID对T细胞显示出相当于全长RANTES的趋化活性。与T细胞相比,截短的RANTES对纯化的单核细胞的趋化作用不明显,补充sCD26而不是mCD26可降低单核细胞对RANTES的趋化反应。这些结果提示CD26/DPPIV对RANTES的趋化反应具有差异性调节T细胞和单核细胞对RANTES的趋化反应,这一发现可以部分解释体内慢性炎症部位的优势表型。基质细胞衍生因子1α(SDF-1α)是一种趋化因子,可预防T嗜性HIV毒株的感染,可能是CD26/DPPIV的底物。我们发现SDF-1α在N末端被CD26/DPPIV切割,导致SDF-1α对HIV感染的抑制作用消失。此外,SDF-1α的趋化活性也被重组可溶性CD26的DPPIV活性特异性地消失。这些结果表明,CD26/DPPIV可能通过失活功能性SDF-1α促进T嗜性HIV毒株在体内的传播。较少
英文摘要
CD26, a 110 kDa cell surface glycoprotein, exhibits dipeptidyl peptidase IV (DPPIV ; EC3.4.14.5) enzyme activity and plays an important role in T cell costimulation. the function of CD26/dipeptidyl peptidase IV in transendothelial migration was examined using beta-chemokines as chemoattractants. When soluble recombinant CD26 (sCD26/DPPIV^+) was added to the transendothelial chemotaxis system, chemotactic migration of T cells toward RANTES was significantly enhanced. Addition of sCD26 to 50 ng/ml of RANTES enhanced the migratory response by a factor of two compared to RANTES alone, whereas mutant soluble CD26, lacking the DPPIV enzyme activity, had no enhancing effect on RANTES-induced T cell migration. In the process of analyzing the mechanisms of the enhancement of T cell migration by sCD26, we showed that RANTES was cleaved by sCD26 under physiologic conditions at the precise site characteristic of its enzyme specificity. However, synthesized RANTES which lacks two N-terminal amino a … More cids showed a chemotactic activity equivalent to full length RANTES on T cells. Furthermore, addition of sCD26 showed enhancement of T cell migration induced by both forms of RANTES.In contrast to T cells, the truncated RANTES is inactive in chemotaxis of purified monocytes, and supplement of sCD26 but not mCD26 reduced the migratory response of monocytes to RANTES.These results suggest that CD26/DPPIV differentially regulate the chemotactic response of T cells and monocytes to RANTES and furthermore, the finding can partly explain the dominant phenotype at the chronic inflammatory sites in vivo. Stromal cell-derived factor 1alpha (SDF-1alpha) is a chemokine that has been shown to prevent infection of T-tropic HIV strains and is a possible substrate of CD26/DPPIV.We have shown that SDF-1alpha was cleaved at the N-terminal region by CD26/DPPIV and as a result, the inhibitory activity of SDF-1alpha against HIV infection was disappeared. Moreover, the chemotactic activity of SDF-1alpha was also disappeared specifically by DPPIV activity of recombinant soluble CD26. These results suggested that dissemination of T-tropic HIV strains in vivo may be facilitated by CD26/DPPIV via inactivation of functional SDF-1alpha. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Ohtsuki T: "Negative regulation of the anti‐HIV and chemotactic activity of human stromal cell-derived factor 1α by CD26/DPPIV." FEBS Letter. 431. 236-240 (1998)
Ohtsuki T:“CD26/DPPIV 对人基质细胞衍生因子 1α 的抗 HIV 和趋化活性的负调节。”FEBS Letter。431. 236-240 (1998)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hegen M: "Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase." Immunol.90. 257-264 (1997)
Hegen M:“抗体交联 CD26 会诱导酪氨酸磷酸化和丝裂原激活蛋白激酶的激活。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hegen M,Kameoka J,Dong RP,Schlossman SF,and Morimoto C.: "Cross-linking of CD26 by antibody induces tyrosine phosphorylation and activation of mitogen-activated protein kinase." Immunol.90. 257-264 (1997)
Hegen M、Kameoka J、Dong RP、Schlossman SF 和 Morimoto C.:“抗体交联 CD26 会诱导酪氨酸磷酸化和丝裂原激活蛋白激酶的激活。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Dong R-P,Tachibana K,Hegen M,Soherpe S,Cho D,Schlossman SF,and Morimoto C.: "Correlation of the epitope defined by anti-CD26 mAbs and CD26 function." Mol.Immunol.35. 13-21 (1998)
Dong R-P、Tachibana K、Hegen M、Soherpe S、Cho D、Schlossman SF 和 Morimoto C.:“抗 CD26 mAb 定义的表位与 CD26 功能的相关性。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Dong R-P,Umezawa Y,Ikushima H,Munakata Y,Schlossman SF,and Morimoto C.: "Different regulatory effects of pentoxifylline on human T cell activation pathways." J.Clin.Immunol.17. 247-252 (1997)
Dong R-P、Umezawa Y、Ikushima H、Munakata Y、Schlossman SF 和 Morimoto C.:“己酮可可碱对人类 T 细胞激活途径的不同调节作用。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 14 条
Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
-
批准号:24659401
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.33万
-
财政年份:2012
-
负责人:MORIMOTO Chikao
-
依托单位:
To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
-
批准号:22650223
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.12万
-
财政年份:2010
-
负责人:MORIMOTO Chikao
-
依托单位:
Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
-
批准号:22390200
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:MORIMOTO Chikao
-
依托单位:
Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
-
批准号:17109011
-
项目类别:Grant-in-Aid for Scientific Research (S)
-
资助金额:$71.72万
-
财政年份:2005
-
负责人:MORIMOTO Chikao
-
依托单位:
Basic study of molecular target therapy for autoimmune diseases and immune deficiency diseases based on CD26
-
批准号:15209033
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$26.79万
-
财政年份:2003
-
负责人:MORIMOTO Chikao
-
依托单位:
The development of specific immune regulatory drugs utilizing the structure and function of CD26
-
批准号:13557039
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.75万
-
财政年份:2001
-
负责人:MORIMOTO Chikao
-
依托单位:
Analysis of the function of lymphocyte adhesion molecules and its clinical significances in autoimmune diseases
-
批准号:13470107
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.43万
-
财政年份:2001
-
负责人:MORIMOTO Chikao
-
依托单位:
Analysis of CD29/VLA integrin in T cell immune regulation and its clinical significance
-
批准号:11307009
-
项目类别:Grant-in-Aid for Scientific Research (A).
-
资助金额:$23.42万
-
财政年份:1999
-
负责人:MORIMOTO Chikao
-
依托单位:
Structure and function of memory T cell marker CD26
-
批准号:11694248
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$2.56万
-
财政年份:1999
-
负责人:MORIMOTO Chikao
-
依托单位:
Development of specific imuune regulatoly drugs by the cell surface molecules.
-
批准号:10557049
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.06万
-
财政年份:1998
-
负责人:MORIMOTO Chikao
-
依托单位:
Determination of molecular basis of immunoregulation of human T cell circuit and its clinical significances
-
批准号:09307009
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$21.57万
-
财政年份:1997
-
负责人:MORIMOTO Chikao
-
依托单位:
Development of immunoregulatory therapy via CD26 activation pathway.
-
批准号:08557036
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$10.18万
-
财政年份:1996
-
负责人:MORIMOTO Chikao
-
依托单位:
海外基金